SGC E&C Co., Ltd. (KOSDAQ:016250)
17,820
+1,020 (6.07%)
At close: Mar 20, 2026
SGC E&C Revenue
In the year 2025, SGC E&C had annual revenue of 1.34T KRW with 11.32% growth. SGC E&C had revenue of 350.24B in the quarter ending December 31, 2025, a decrease of -7.41%.
Revenue
1.34T
Revenue Growth
+11.32%
P/S Ratio
0.07
Revenue / Employee
1.85B
Employees
727
Market Cap
89.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.34T | 136.45B | 11.32% |
| Dec 31, 2024 | 1.21T | -658.09B | -35.31% |
| Dec 31, 2023 | 1.86T | 340.35B | 22.34% |
| Dec 31, 2022 | 1.52T | 215.41B | 16.47% |
| Dec 31, 2021 | 1.31T | 172.17B | 15.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dong-A Hwa Sung | 405.21B |
| Woowon Development | 379.63B |
| The LEADCORP | 367.17B |
| Ahn-Gook Pharmaceutical | 300.96B |
| Huvitz | 120.56B |
| DE&T Co., Ltd. | 96.81B |
| HS Valve | 84.43B |
| KoBioLabs | 71.83B |